HCA Healthcare Q2 EPS Forecast Raised by Leerink Partnrs

HCA Healthcare, Inc. (NYSE:HCA) – Research analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for shares of HCA Healthcare in a report issued on Wednesday, October 23rd. Leerink Partnrs analyst W. Mayo now forecasts that the company will earn $6.53 per share for the quarter, up from their previous estimate of $6.52. The consensus estimate for HCA Healthcare’s current full-year earnings is $22.51 per share. Leerink Partnrs also issued estimates for HCA Healthcare’s Q3 2025 earnings at $5.77 EPS, Q4 2025 earnings at $7.44 EPS and FY2025 earnings at $25.79 EPS.

A number of other research firms have also recently weighed in on HCA. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Morgan Stanley assumed coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $365.00 to $395.00 and gave the company an “equal weight” rating in a report on Tuesday. Finally, Barclays lifted their price objective on HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a report on Wednesday, July 24th. Five equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and four have issued a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $367.15.

HCA Healthcare Trading Down 2.7 %

NYSE HCA opened at $398.90 on Friday. The company has a debt-to-equity ratio of 27.11, a current ratio of 1.06 and a quick ratio of 0.94. The company has a fifty day moving average of $394.72 and a 200 day moving average of $352.30. HCA Healthcare has a 1 year low of $220.55 and a 1 year high of $417.14. The company has a market capitalization of $104.48 billion, a PE ratio of 19.89, a P/E/G ratio of 1.44 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The firm had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same period in the previous year, the company earned $4.29 earnings per share. The business’s quarterly revenue was up 10.3% compared to the same quarter last year.

HCA Healthcare Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a dividend yield of 0.66%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Insiders Place Their Bets

In other news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the sale, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction dated Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now directly owns 40,449 shares in the company, valued at approximately $14,569,729.80. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,345 shares of company stock worth $5,747,945 over the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of HCA. CreativeOne Wealth LLC acquired a new position in HCA Healthcare in the 1st quarter valued at about $231,000. New Mexico Educational Retirement Board lifted its holdings in shares of HCA Healthcare by 29.9% during the first quarter. New Mexico Educational Retirement Board now owns 13,900 shares of the company’s stock worth $4,636,000 after purchasing an additional 3,200 shares during the period. Kingswood Wealth Advisors LLC purchased a new position in HCA Healthcare during the 1st quarter worth $566,000. Bessemer Group Inc. boosted its holdings in shares of HCA Healthcare by 51.2% in the first quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after acquiring an additional 2,584 shares in the last quarter. Finally, Empowered Funds LLC lifted its position in HCA Healthcare by 54.3% in the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock valued at $4,639,000 after purchasing an additional 4,893 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.